Patrick Ronan

Board of Directors

 

Patrick Ronan serves on the Board of Directors at Symbio and is currently an Operating Partner at ARCHIMED, a global investment firm focused on the healthcare sector. He brings extensive leadership experience in the life sciences industry, having previously served as CEO of Validant (now Eliquent Life Sciences) and as founder and CEO of Greenleaf Health.

Earlier in his career, Patrick was Vice President of Regulatory Policy & External Affairs at Novartis and held a senior executive role as Chief of Staff at the U.S. Food and Drug Administration (FDA), where he oversaw strategic, operational, and regulatory policy initiatives.